SCHOTT delivers pharma vials to package 2 billion doses of COVID-19 vaccines

SCHOTT supports the world’s fight against COVID-19 with vials capable of holding up to 2 billion vaccination doses. The glassmaker and pharma packaging specialist has reached agreements with leading pharmaceutical companies, including partners of ‘Operation Warp Speed’ – the US government initiative to serve local vaccine production needs. The agreements become effective immediately and first vials are being delivered to companies in North America, Europe and Asia. SCHOTT is ideally positioned to meet the challenging demand situation, as it has been maintaining a global and already validated production network for decades. Even before the expansion, the company already produced more than 11 billion pharma containers for life-saving drugs per annum.

“We have invested €350 million in recent months. Demand for high-quality pharma packaging has been high before Coronavirus. The fact that we had set up an investment program in 2019 now enables us to ramp up production quickly.“
Dr. Frank Heinricht, Chairman of SCHOTT’s Management Board

Read the full press release here.

June 26th, 2020

Salvatore Ruggiero
Marketing and Communication
SCHOTT AG

top